161 related articles for article (PubMed ID: 7913275)
1. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
[TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B.
Laughlin MA; Chang GY; Oakes JW; Gonzalez-Scarano F; Pomerantz RJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):332-9. PubMed ID: 7600100
[TBL] [Abstract][Full Text] [Related]
3. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
[TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K
Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
[TBL] [Abstract][Full Text] [Related]
7. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
[TBL] [Abstract][Full Text] [Related]
8. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines.
Israël N; Gougerot-Pocidalo MA; Aillet F; Virelizier JL
J Immunol; 1992 Nov; 149(10):3386-93. PubMed ID: 1431113
[TBL] [Abstract][Full Text] [Related]
9. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
10. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
11. An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte.
Conant K; Atwood WJ; Traub R; Tornatore C; Major EO
Virology; 1994 Dec; 205(2):586-90. PubMed ID: 7975262
[TBL] [Abstract][Full Text] [Related]
12. Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins.
Qian J; Bours V; Manischewitz J; Blackburn R; Siebenlist U; Golding H
J Immunol; 1994 Apr; 152(8):4183-91. PubMed ID: 8144979
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor.
Kruppa G; Thoma B; Machleidt T; Wiegmann K; Krönke M
J Immunol; 1992 May; 148(10):3152-7. PubMed ID: 1315830
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.
Israël N; Hazan U; Alcami J; Munier A; Arenzana-Seisdedos F; Bachelerie F; Israël A; Virelizier JL
J Immunol; 1989 Dec; 143(12):3956-60. PubMed ID: 2574206
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
16. Effects of CD45 on NF-kappa B. Implications for replication of HIV-1.
Baur A; Garber S; Peterlin BM
J Immunol; 1994 Feb; 152(3):976-83. PubMed ID: 7905504
[TBL] [Abstract][Full Text] [Related]
17. NF- kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and superoxide production.
Tummala PE; Chen XL; Medford RM
J Mol Cell Cardiol; 2000 Aug; 32(8):1499-508. PubMed ID: 10900176
[TBL] [Abstract][Full Text] [Related]
18. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A.
Thévenin C; Kim SJ; Rieckmann P; Fujiki H; Norcross MA; Sporn MB; Fauci AS; Kehrl JH
New Biol; 1990 Sep; 2(9):793-800. PubMed ID: 2177654
[TBL] [Abstract][Full Text] [Related]
19. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
Bernier R; Barbeau B; Tremblay MJ; Olivier M
J Immunol; 1998 Mar; 160(6):2881-8. PubMed ID: 9510191
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection.
Moriuchi H; Moriuchi M; Fauci AS
J Immunol; 1997 Apr; 158(7):3483-91. PubMed ID: 9120310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
